Hospital de Gran Canaria Dr. Negrin -ko ikertzaileekin lankidetzan egindako argitalpenak (25)

2024

  1. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  2. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

2023

  1. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

  2. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease

    Respiratory Research, Vol. 23, Núm. 1

2021

  1. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD

    Chest, Vol. 160, Núm. 3, pp. 872-878

  2. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

  3. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 8, pp. 533-539

2020

  1. Somatotypes trajectories during adulthood and their association with copd phenotypes

    ERJ Open Research, Vol. 6, Núm. 3, pp. 1-9

2019

  1. Prognostic Validation Using GesEPOC 2017 Severity Criteria

    Archivos de Bronconeumologia

  2. Validación pronóstica según los criterios de la GesEPOC 2017

    Archivos de bronconeumologia, Vol. 55, Núm. 8, pp. 409-413

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

  2. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort

    PLoS ONE, Vol. 13, Núm. 2

  3. Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports impact on grouping and outcomes

    American Journal of Respiratory and Critical Care Medicine, Vol. 197, Núm. 4, pp. 463-469

2017

  1. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

2016

  1. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: A pilot study

    International Journal of COPD, Vol. 11, Núm. 1, pp. 1217-1222

  2. Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort

    PLoS ONE, Vol. 11, Núm. 9

  3. Simplificando las guías: los 10 mandamientos de la EPOC

    Archivos de Bronconeumologia, Vol. 52, Núm. 4, pp. 179-180

2015

  1. COPD comorbidities network

    European Respiratory Journal, Vol. 46, Núm. 3, pp. 640-650

  2. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD

    Chest, Vol. 148, Núm. 1, pp. 159-168